Medicare Enrolled
Dr. Tooraj Zahedi, MD
Endocrinology · Forest Hills, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zahedi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zahedi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zahedi
Dr. Tooraj Zahedi is an endocrinology specialist in Forest Hills, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zahedi performed 2,314 Medicare services across 1,486 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zahedi received a total of $35,559 from 59 pharmaceutical and/or device companies across 767 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zahedi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NY
$35,559 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,314
Medicare services
Top 25% in NY for endocrinology
1,486
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~116 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
685 | $111 | $450 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
473 | $3 | $50 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
231 | $103 | $500 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
147 | $77 | $450 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
108 | $81 | $150 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
108 | $114 | $300 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
105 | $75 | $300 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
97 | $30 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $78 | $450 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $154 | $550 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
56 | $49 | $70 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
46 | $107 | $200 |
| Lung function test measuring exhaled air A test that measures the air you exhale to evaluate how well your lungs are functioning while at rest. |
27 | $46 | $63 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $13 | $27 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
23 | $141 | $350 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
21 | $116 | $147 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $99 | $550 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $158 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$35,559
Total received (2018-2024)
Avg $5,080/year across 7 years
Top 12% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
767
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,668 (46.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,983 (44.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,908 (8.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,096
2023
$8,049
2022
$2,662
2021
$4,315
2020
$2,178
2019
$5,291
2018
$5,968
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Mannkind Corporation
$4,497
CeQur Corporation
$530
Corcept Therapeutics
$236
Amgen Inc.
$197
Novo Nordisk Inc
$194
Chiesi USA, Inc.
$183
SANOFI-AVENTIS U.S. LLC
$171
Xeris Pharmaceuticals, Inc.
$154
Bayer Healthcare Pharmaceuticals Inc.
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$141
Lilly USA, LLC
$137
Novartis Pharmaceuticals Corporation
$118
Tandem Diabetes Care, Inc.
$62
Abbott Laboratories
$52
IBSA Pharma Inc.
$46
Insulet Corporation
$42
ABBVIE INC.
$30
Intra-Sana Laboratories
$29
BETA BIONICS, INC.
$29
Amneal Pharmaceuticals LLC
$28
Astellas Pharma US Inc
$25
Radius Health, Inc.
$23
Neurocrine Biosciences, Inc.
$18
Amphastar Pharmaceuticals, Inc.
$15
Top 3 companies account for 74.2% of 2024 payments
All-time payments by company (2018-2024) ›
MannKind Corporation
$6,293
Mannkind Corporation
$5,568
AbbVie, Inc.
$3,849
Corcept Therapeutics
$3,750
AbbVie Inc.
$2,327
Lilly USA, LLC
$1,334
Novo Nordisk Inc
$1,319
Amgen Inc.
$1,202
SANOFI-AVENTIS U.S. LLC
$1,032
Boehringer Ingelheim Pharmaceuticals, Inc.
$874
CeQur Corporation
$752
Janssen Pharmaceuticals, Inc
$571
Amarin Pharma Inc.
$538
AstraZeneca Pharmaceuticals LP
$535
Merck Sharp & Dohme Corporation
$401
Bayer Healthcare Pharmaceuticals Inc.
$363
Ipsen Biopharmaceuticals, Inc
$339
Insulet Corporation
$333
Dexcom, Inc.
$332
Horizon Therapeutics plc
$280
Amneal Pharmaceuticals LLC
$269
Xeris Pharmaceuticals, Inc.
$264
Amryt Pharma Holdings Ltd
$247
IBSA Pharma Inc.
$245
Novartis Pharmaceuticals Corporation
$219
Tandem Diabetes Care, Inc.
$213
Chiesi USA, Inc.
$183
Vanda Pharmaceuticals Inc.
$168
Abbott Laboratories
$134
PFIZER INC.
$129
Medtronic MiniMed, Inc.
$127
Shire North American Group Inc
$124
Radius Health, Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$95
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$78
Intra-Sana Laboratories
$77
Astellas Pharma US Inc
$75
Eisai Inc.
$72
Becton, Dickinson and Company
$66
Ascendis Pharma Inc
$63
Regeneron Healthcare Solutions, Inc.
$60
ABBVIE INC.
$59
DEXCOM, INC.
$58
VistaPharm, Inc.
$51
RECORDATI_RARE_DISEASES_INC.
$47
Valeritas, Inc.
$46
Renalytix AI, Inc.
$36
Medtronic, Inc.
$31
Horizon Pharma plc
$31
BETA BIONICS, INC.
$29
Zealand Pharma US, Inc.
$24
Esperion Therapeutics, Inc.
$22
Nevro Corp.
$21
Neurocrine Biosciences, Inc.
$18
Acerus Pharmaceuticals Corporation
$17
Averitas Pharma Inc.
$17
Ultragenyx Pharmaceutical Inc.
$16
Merck Sharp & Dohme LLC
$15
Amphastar Pharmaceuticals, Inc.
$15
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · CYCLOSET · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · Korlym · LEQVIO · LICART · Lenvima · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Natesto · Omnia · Omnipod · Ozempic · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · RECORLEV · RELTONE 200 MG · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNJARDY · SYNTHROID · Saxenda · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · XARELTO · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (47%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Endocrinologists within 10 mi
639
Per 100K population
27.4
County median income
$84,961
Nearest hospital
JAMAICA HOSPITAL MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zahedi is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with speaking/promotional industry engagement in the top 12% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zahedi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zahedi performed 685 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zahedi receive payments from pharmaceutical companies?
Yes. Dr. Zahedi received a total of $35,559 from 59 companies across 767 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zahedi's costs compare to other endocrinologists in Forest Hills?
Dr. Zahedi's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zahedi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Forest Hills
Browse endocrinologists in Forest Hills ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
MannKind Corporation Payments to Doctors
See all physicians who received payments from MannKind Corporation.
By company
Mannkind Corporation Payments to Doctors
See all physicians who received payments from Mannkind Corporation.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology